ECO ANIMAL HEALTH GROUP PLC |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 125 GBX | -0.40% |
|
-3.85% | +15.21% |
| 05-08 | TRADING UPDATES: ECO hails vaccine results; Plant Health sales down | AN |
| 04-25 | EARNINGS AND TRADING: ECO Animal revenue up; Zephyr starts drilling | AN |
Valuation
| Fiscal Period: März | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Capitalization 1 | 296.7 | 148.6 | 217.8 | 109.7 | 65.35 | 84.68 | - | - |
| Enterprise Value (EV) 1 | 278.7 | 140.5 | 199.8 | 97.31 | 48.17 | 65.24 | 66.51 | 65.51 |
| P/E ratio | 25.4 x | 59.9 x | 26.7 x | -160 x | 65.6 x | 54 x | 43.4 x | 29.8 x |
| Yield | 2.51% | - | 0.31% | - | - | - | 0.56% | 0.72% |
| Capitalization / Revenue | 3.98 x | 2.06 x | 2.06 x | 1.33 x | 0.77 x | 0.95 x | 0.91 x | 0.86 x |
| EV / Revenue | 3.74 x | 1.95 x | 1.89 x | 1.18 x | 0.56 x | 0.73 x | 0.72 x | 0.66 x |
| EV / EBITDA | 14 x | 16.8 x | 8.19 x | 18 x | 6.66 x | 8.34 x | 7.99 x | 7.07 x |
| EV / FCF | - | 38.7 x | 17 x | -44.8 x | 3.9 x | 58 x | 22.5 x | 19.3 x |
| FCF Yield | - | 2.58% | 5.89% | -2.23% | 25.6% | 1.72% | 4.45% | 5.17% |
| Price to Book | 2.77 x | 1.86 x | 2.62 x | 1.34 x | 0.78 x | 0.95 x | 0.93 x | 0.91 x |
| Nbr of stocks (in thousands) | 67,443 | 67,548 | 67,548 | 67,722 | 67,722 | 67,745 | - | - |
| Reference price 2 | 4.400 | 2.200 | 3.225 | 1.620 | 0.9650 | 1.250 | 1.250 | 1.250 |
| Announcement Date | 19/06/19 | 04/02/21 | 26/07/21 | 31/08/22 | 10/07/23 | - | - | - |
1GBP in Million2GBP
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: März | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Net sales 1 | 74.58 | 72.11 | 105.6 | 82.2 | 85.31 | 89.47 | 92.65 | 98.71 |
| EBITDA 1 | 19.95 | 8.362 | 24.4 | 5.406 | 7.235 | 7.827 | 8.329 | 9.268 |
| EBIT 1 | 14.67 | 5.195 | 20.32 | 4.06 | 4.947 | 5.074 | 5.4 | 6.114 |
| Operating Margin | 19.67% | 7.2% | 19.24% | 4.94% | 5.8% | 5.67% | 5.83% | 6.19% |
| Earnings before Tax (EBT) 1 | 15.25 | 5.207 | 20.28 | 1.389 | 4.44 | 4.638 | 5.136 | 5.971 |
| Net income 1 | - | - | 8.158 | -0.686 | 1.008 | 2.2 | 2.6 | 2.65 |
| Net margin | - | - | 7.72% | -0.83% | 1.18% | 2.46% | 2.81% | 2.68% |
| EPS 2 | 0.1735 | 0.0367 | 0.1207 | -0.0101 | 0.0147 | 0.0231 | 0.0288 | 0.0420 |
| Free Cash Flow 1 | - | 3.631 | 11.77 | -2.172 | 12.34 | 1.124 | 2.958 | 3.387 |
| FCF margin | - | 5.04% | 11.14% | -2.64% | 14.47% | 1.26% | 3.19% | 3.43% |
| FCF Conversion (EBITDA) | - | 43.42% | 48.23% | - | 170.62% | 14.36% | 35.51% | 36.54% |
| FCF Conversion (Net income) | - | - | 144.26% | - | 1,224.6% | 51.09% | 113.77% | 127.81% |
| Dividend per Share 2 | 0.1104 | - | 0.0100 | - | - | - | 0.007000 | 0.009000 |
| Announcement Date | 19/06/19 | 04/02/21 | 26/07/21 | 31/08/22 | 10/07/23 | - | - | - |
1GBP in Million2GBP
Estimates
Income Statement Evolution (Quarterly data)
| Fiscal Period: März | 2022 S1 | 2022 S2 | 2023 S1 | 2023 S2 |
|---|---|---|---|---|
| Net sales 1 | - | 43.72 | - | 50.45 |
| EBITDA 1 | - | 1.625 | - | 5.565 |
| EBIT | - | - | - | - |
| Operating Margin | - | - | - | - |
| Earnings before Tax (EBT) | - | - | - | - |
| Net income | -0.14 | - | 1.325 | - |
| Net margin | - | - | - | - |
| EPS | -0.002100 | - | 0.0195 | - |
| Dividend per Share | - | - | - | - |
| Announcement Date | 25/11/21 | 31/08/22 | 23/11/22 | 10/07/23 |
1GBP in Million
Estimates
Balance Sheet Analysis
| Fiscal Period: März | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Net Debt 1 | - | - | - | - | - | - | - | - |
| Net Cash position 1 | 18.1 | 8.08 | 18 | 12.4 | 17.2 | 19.4 | 18.2 | 19.2 |
| Leverage (Debt/EBITDA) | - | - | - | - | - | - | - | - |
| Free Cash Flow 1 | - | 3.63 | 11.8 | -2.17 | 12.3 | 1.12 | 2.96 | 3.39 |
| ROE (net income / shareholders' equity) | - | - | 10.3% | -0.84% | 1.22% | 1.9% | 2.5% | 2.8% |
| ROA (Net income/ Total Assets) | - | - | - | - | - | - | - | - |
| Assets 1 | - | - | - | - | - | - | - | - |
| Book Value Per Share 2 | 1.590 | 1.180 | 1.230 | 1.210 | 1.230 | 1.310 | 1.340 | 1.380 |
| Cash Flow per Share | 0 | 0.0600 | 0 | - | - | - | - | - |
| Capex 1 | - | - | 0.21 | 1.62 | 3.56 | 1.75 | 1.55 | 0.5 |
| Capex / Sales | - | - | 0.2% | 1.98% | 4.18% | 1.96% | 1.67% | 0.51% |
| Announcement Date | 19/06/19 | 04/02/21 | 26/07/21 | 31/08/22 | 10/07/23 | - | - | - |
1GBP in Million2GBP
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Year-on-year evolution of the Yield
Change in Enterprise Value/EBITDA
Trading Rating
Investor Rating
ESG Refinitiv
C
Sell
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
1.25
GBP
Average target price
1.89
GBP
Spread / Average Target
+51.17%
EPS Revisions
Annual profits - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| +15.21% | 108M | |
| -12.16% | 80.52B | |
| -3.15% | 7.05B | |
| +21.25% | 3.56B | |
| -9.18% | 3B | |
| +16.05% | 1.71B | |
| -8.50% | 1.21B | |
| -33.05% | 1.11B | |
| -36.85% | 1.06B | |
| -27.92% | 944M |
- Stock Market
- Equities
- EAH Stock
- Financials ECO Animal Health Group plc
